Current and historical daily PE Ratio for Betta Pharmaceuticals Co Ltd (
SZSE:300558
) from 2016 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Betta Pharmaceuticals stock (SZSE:300558) PE ratio as of Jun 05 2024 is 40.95.
More Details
Betta Pharmaceuticals Co Ltd (SZSE:300558) PE Ratio (TTM) Chart
Betta Pharmaceuticals Co Ltd (SZSE:300558) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1198
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Betta Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-05 | 41.0 | 2024-03-27 | 49.5 |
| 2024-06-04 | 41.3 | 2024-03-26 | 51.9 |
| 2024-06-03 | 40.3 | 2024-03-25 | 53.1 |
| 2024-05-31 | 40.7 | 2024-03-22 | 54.1 |
| 2024-05-30 | 40.9 | 2024-03-21 | 54.9 |
| 2024-05-29 | 41.3 | 2024-03-20 | 56.4 |
| 2024-05-28 | 40.6 | 2024-03-19 | 56.1 |
| 2024-05-27 | 40.5 | 2024-03-18 | 57.0 |
| 2024-05-24 | 40.9 | 2024-03-15 | 58.0 |
| 2024-05-23 | 41.0 | 2024-03-14 | 57.2 |
| 2024-05-22 | 42.4 | 2024-03-13 | 53.8 |
| 2024-05-21 | 42.3 | 2024-03-12 | 51.8 |
| 2024-05-20 | 43.0 | 2024-03-11 | 51.2 |
| 2024-05-17 | 44.0 | 2024-03-08 | 49.7 |
| 2024-05-16 | 43.6 | 2024-03-07 | 50.0 |
| 2024-05-15 | 43.9 | 2024-03-06 | 52.5 |
| 2024-05-14 | 44.8 | 2024-03-05 | 53.2 |
| 2024-05-13 | 45.7 | 2024-03-04 | 54.2 |
| 2024-05-10 | 46.1 | 2024-03-01 | 53.2 |
| 2024-05-09 | 47.5 | 2024-02-29 | 52.8 |
| 2024-05-08 | 46.5 | 2024-02-28 | 51.8 |
| 2024-05-07 | 47.3 | 2024-02-27 | 53.2 |
| 2024-05-06 | 47.0 | 2024-02-26 | 52.3 |
| 2024-04-30 | 44.9 | 2024-02-23 | 51.8 |
| 2024-04-29 | 44.7 | 2024-02-22 | 51.6 |
| 2024-04-26 | 43.6 | 2024-02-21 | 51.6 |
| 2024-04-25 | 42.0 | 2024-02-20 | 51.6 |
| 2024-04-24 | 42.0 | 2024-02-19 | 51.5 |
| 2024-04-23 | 41.6 | 2024-02-08 | 52.0 |
| 2024-04-22 | 41.2 | 2024-02-07 | 52.8 |
| 2024-04-19 | 38.8 | 2024-02-06 | 48.0 |
| 2024-04-18 | 39.1 | 2024-02-05 | 42.7 |
| 2024-04-17 | 39.7 | 2024-02-02 | 44.1 |
| 2024-04-16 | 38.9 | 2024-02-01 | 45.5 |
| 2024-04-15 | 40.4 | 2024-01-31 | 46.2 |
| 2024-04-12 | 40.8 | 2024-01-30 | 48.3 |
| 2024-04-11 | 41.9 | 2024-01-29 | 49.6 |
| 2024-04-10 | 42.1 | 2024-01-26 | 50.0 |
| 2024-04-09 | 43.0 | 2024-01-25 | 51.5 |
| 2024-04-08 | 41.9 | 2024-01-24 | 50.7 |
| 2024-04-03 | 43.3 | 2024-01-23 | 50.7 |
| 2024-04-02 | 43.8 | 2024-01-22 | 50.0 |
| 2024-04-01 | 44.9 | 2024-01-19 | 53.3 |
| 2024-03-29 | 44.0 | 2024-01-18 | 54.3 |
| 2024-03-28 | 44.0 | 2024-01-17 | 54.1 |
Betta Pharmaceuticals Co Ltd (SZSE:300558) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Betta Pharmaceuticals Co Ltd
ISIN : CNE100002DD9
Share Class Description:
SZSE:300558: Class ACompare
Compare
Traded in other countries / regions
300558.China IPO Date
2016-11-07Description
Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers